Fundraising Fox
Find your path to Sam
Sign up to see every warm intro you have to Sam
- Paths you didn't know you had: your email and LinkedIn already hold routes to Sam. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Sam Tetlow is Co-Founder and Chief Scientific Officer of Amalgent Therapeutics, where he leads development of a CNS therapeutic based on a combination of two small molecules and has secured $2.8M in SBIR funding as principal investigator. Through ZForm, LLC, he advises biopharma clients on development strategy, regulatory pathways, and non-dilutive funding, work that has contributed to over $20M in non-dilutive funding across small molecules, biologics, devices, and diagnostics. His earlier career includes more than a decade of stem cell research as a Howard Hughes Medical Institute Fellow at the University of Pennsylvania and a Research Professor at the University of Pittsburgh, followed by directing preclinical programs at Noveome Biotherapeutics.
Co-founder, President & Executive Chair at Amalgent
Intro paths
In turn, Sam can intro founders to Amalgent's investors below.
Amalgent's investors · 1
Co-founders at Amalgent
Co-founder & Chief Scientific Officer at Amalgent
Intro paths
In turn, Sam can intro founders to Amalgent's investors below.
Amalgent's investors · 1
Co-founders at Amalgent
Frequently asked questions
- Who is Sam Tetlow?
- Sam Tetlow is Co-Founder and Chief Scientific Officer of Amalgent Therapeutics, where he leads development of a CNS therapeutic based on a combination of two small molecules and has secured $2.8M in SBIR funding as principal investigator. Through ZForm, LLC, he advises biopharma clients on development strategy, regulatory pathways, and non-dilutive funding, work that has contributed to over $20M in non-dilutive funding across small molecules, biologics, devices, and diagnostics. His earlier career includes more than a decade of stem cell research as a Howard Hughes Medical Institute Fellow at the University of Pennsylvania and a Research Professor at the University of Pittsburgh, followed by directing preclinical programs at Noveome Biotherapeutics.
- Where does Sam Tetlow work?
- Sam Tetlow is Co-founder, President & Executive Chair of Amalgent.
- What companies did Sam Tetlow found?
- Sam Tetlow founded Amalgent.
Founder mafias
University of Arizona mafia126
Also came through, then founded or led a company.
Macalester College mafia17
Also came through, then founded or led a company.
The George Washington University School of Medicine and Health Sciences mafia14
Also came through, then founded or led a company.
Noveome Biotherapeutics mafia2
Also came through, then founded or led a company.
Walnut Hills High School mafia2
Also came through, then founded or led a company.
About this profile. Compiled from public sources — Amalgent's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights